இந்தியன் காப்புரிமை நாடகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Synopsis The National Pharmaceutical Pricing Authority (NPPA) gave its nod to price cap exemption for Torrent’s nasal spray used for pain relief under Para 32 of the Drug Price Control Order (DPCO) 2013, which is applicable when a new drug developed through a unique, indigenous process, is patented under the Indian Patent Act, 1970, and is not produced elsewhere. Agencies The country’s drug pricing regulator has granted a rare exemption to Torrent Pharmaceuticals’ tapendatol nasal spray from price caps, and approved a one-time price hike of 50% from the ceiling for key drugs carbamazepine, ranitidine and ibuprofen. The National Pharmaceutical Pricing Authority (NPPA) gave its nod to price cap exemption for Torrent’s nasal spray used for pain relief under Para 32 of the Drug Price Control Order (DPCO) 2013, which is applicable when a new drug developed through a unique, indigenous process, is patented under the Indian Patent Act, 1970, and is not produced elsewhere.

National pharmaceutical pricing authorityDrug price control orderIndian patent actதேசிய மருந்து ப்ரைஸிஂக் அதிகாரம்மருந்து ப்ரைஸ் கட்டுப்பாடு ஆர்டர்இந்தியன் காப்புரிமை நாடகம்